Axsome Therapeutics Wins FDA Nod for Auvelity in Alzheimer’s Agitation, Launch Set for June thelincolnianonline · May 3, 2026 · 1 min read Clinically Reviewed by Editorial Advisory Panel alzheimers-dementia Originally reported by thelincolnianonline. Read more Source: https://www.thelincolnianonline.com/2026/05/01/axsome-therapeutics-wins-fda-nod-for-auvelity-in-alzheimers-agitation-launch-set-for-june.html
